0001567619-20-010647.txt : 20200518 0001567619-20-010647.hdr.sgml : 20200518 20200518123650 ACCESSION NUMBER: 0001567619-20-010647 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 EFFECTIVENESS DATE: 20200518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QurAlis Corp CENTRAL INDEX KEY: 0001811817 IRS NUMBER: 814722156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367164 FILM NUMBER: 20888595 BUSINESS ADDRESS: STREET 1: 700 MAIN STREET, NORTH CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 781-816-7031 MAIL ADDRESS: STREET 1: 700 MAIN STREET, NORTH CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001811817 QurAlis Corp 700 MAIN STREET, NORTH CAMBRIDGE MA MASSACHUSETTS 02139 781-816-7031 DELAWARE None None Corporation true 2016 Kasper C.D. Roet c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Director Executive Officer Promoter Mr. Roet is the Chief Executive Office of the Issuer. Chris Thomajan c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Executive Officer Mr. Thomajan is the Chief Financial Officer of the Issuer. Daniel Elbaum c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Executive Officer Mr. Elbaum is the Chief Scientific Officer of the Issuer. Amy Schulman c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Director Roel Bulthuis c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Director Luc Dochez c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Director Johannes Fruehauf c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Director Jonathan Fleming c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Director Jonathan Behr c/o QurAlis Corporation 700 Main Street, North Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2020-05-01 false true true Series A-1 Preferred Stock and Series A-2 Preferred Stock false 0 60000000 33222703 26777297 false 25 0 0 0 false QurAlis Corp /s/ Kasper C. D. Roet Kasper C.D. Roet Chief Executive Officer of the Issuer 2020-05-15